228 related articles for article (PubMed ID: 28732151)
1. Patients' Attitudes and Experiences of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis and Spondyloarthritis: A Qualitative Synthesis.
Kelly A; Tymms K; Tunnicliffe DJ; Sumpton D; Perera C; Fallon K; Craig JC; Abhayaratna W; Tong A
Arthritis Care Res (Hoboken); 2018 Apr; 70(4):525-532. PubMed ID: 28732151
[TBL] [Abstract][Full Text] [Related]
2. Rheumatoid Arthritis Patients' Motivations for Accepting or Resisting Disease-Modifying Antirheumatic Drug Treatment Regimens.
Shaw Y; Metes ID; Michaud K; Donohue JM; Roberts MS; Levesque MC; Chang JC
Arthritis Care Res (Hoboken); 2018 Apr; 70(4):533-541. PubMed ID: 28575542
[TBL] [Abstract][Full Text] [Related]
3. Factors influencing clinician prescribing of disease-modifying anti-rheumatic drugs for inflammatory arthritis: A systematic review and thematic synthesis of qualitative studies.
Lalor AF; Brooker JE; Rozbroj T; Whittle SL; Hill CL; Rowett D; Buchbinder R; O'Connor DA
Semin Arthritis Rheum; 2022 Aug; 55():151988. PubMed ID: 35286905
[TBL] [Abstract][Full Text] [Related]
4. Examining Time to Initiation of Biologic Disease-modifying Antirheumatic Drugs and Medication Adherence and Persistence Among Texas Medicaid Recipients With Rheumatoid Arthritis.
Kim G; Barner JC; Rascati K; Richards K
Clin Ther; 2016 Mar; 38(3):646-54. PubMed ID: 26899313
[TBL] [Abstract][Full Text] [Related]
5. Determinants of adherence to disease modifying anti-rheumatic drugs in White British and South Asian patients with rheumatoid arthritis: a cross sectional study.
Kumar K; Raza K; Nightingale P; Horne R; Chapman S; Greenfield S; Gill P
BMC Musculoskelet Disord; 2015 Dec; 16():396. PubMed ID: 26714853
[TBL] [Abstract][Full Text] [Related]
6. Patients' views about treatment with combination therapy for rheumatoid arthritis: a comparative qualitative study.
Lempp H; Hofmann D; Hatch SL; Scott DL
BMC Musculoskelet Disord; 2012 Oct; 13():200. PubMed ID: 23078166
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the utility of visual feedback in the treatment of early rheumatoid arthritis patients: a pilot study.
El Miedany Y; El Gaafary M; Palmer D
Rheumatol Int; 2012 Oct; 32(10):3061-8. PubMed ID: 21909946
[TBL] [Abstract][Full Text] [Related]
8. Essential knowledge for patients with rheumatoid arthritis or spondyloarthritis: Results of a multicentric survey in France among health professionals and patients.
Beauvais C; Rodère M; Pereira B; Legoupil N; Piperno M; Pallot Prades B; Castaing P; Wendling D; Grange L; Costantino F; Carton L; Soubrier M; Coquerelle P; Pham T; Poivret D; Cohen JD; Tavares I; Nataf H; Pouplin S; Sordet C; Gossec L
Joint Bone Spine; 2019 Nov; 86(6):747-752. PubMed ID: 31228620
[TBL] [Abstract][Full Text] [Related]
9. Development and application of a questionnaire to assess patient beliefs in rheumatoid arthritis and axial spondyloarthritis.
Gossec L; Berenbaum F; Chauvin P; Hudry C; Cukierman G; de Chalus T; Dreuillet C; Saulot V; Tong S; Russo-Marie F; Joubert JM; Saraux A
Clin Rheumatol; 2018 Oct; 37(10):2649-2657. PubMed ID: 29948351
[TBL] [Abstract][Full Text] [Related]
10. Risk of cutaneous herpes zoster in patients with spondyloarthritis treated with conventional and biologic disease-modifying antirheumatic drugs.
Wong SCT; Li IWS; Ng AHY; Lau CS; Chung HY
Int J Rheum Dis; 2020 Feb; 23(2):189-196. PubMed ID: 31489783
[TBL] [Abstract][Full Text] [Related]
11. Barriers and facilitators to disease-modifying antirheumatic drug use in patients with inflammatory rheumatic diseases: a qualitative theory-based study.
Voshaar M; Vriezekolk J; van Dulmen S; van den Bemt B; van de Laar M
BMC Musculoskelet Disord; 2016 Oct; 17(1):442. PubMed ID: 27769224
[TBL] [Abstract][Full Text] [Related]
12. Medication adherence and cost-related medication non-adherence in patients with rheumatoid arthritis: A cross-sectional study.
Heidari P; Cross W; Weller C; Nazarinia M; Crawford K
Int J Rheum Dis; 2019 Apr; 22(4):555-566. PubMed ID: 30924291
[TBL] [Abstract][Full Text] [Related]
13. Association of Medication Beliefs, Self-efficacy, and Adherence in a Diverse Cohort of Adults with Rheumatoid Arthritis.
McCulley C; Katz P; Trupin L; Yelin EH; Barton JL
J Rheumatol; 2018 Dec; 45(12):1636-1642. PubMed ID: 30219761
[TBL] [Abstract][Full Text] [Related]
14. 'It's like taking poison to kill poison but I have to get better': a qualitative study of beliefs about medicines in Rheumatoid arthritis and Systemic lupus erythematosus patients of South Asian origin.
Kumar K; Gordon C; Barry R; Shaw K; Horne R; Raza K
Lupus; 2011 Jul; 20(8):837-44. PubMed ID: 21511761
[TBL] [Abstract][Full Text] [Related]
15. Adherence rates and associations with nonadherence in patients with rheumatoid arthritis using disease modifying antirheumatic drugs.
van den Bemt BJ; van den Hoogen FH; Benraad B; Hekster YA; van Riel PL; van Lankveld W
J Rheumatol; 2009 Oct; 36(10):2164-70. PubMed ID: 19723906
[TBL] [Abstract][Full Text] [Related]
16. Economic Burden and Treatment Patterns of Cycling between Conventional Synthetic Disease-modifying Antirheumatic Drugs Among Biologic-treated Patients with Rheumatoid Arthritis.
Betts KA; Griffith J; Ganguli A; Li N; Douglas K; Wu EQ
Clin Ther; 2016 May; 38(5):1205-16. PubMed ID: 27045991
[TBL] [Abstract][Full Text] [Related]
17. Alternative tumour necrosis factor inhibitors (TNFi) or abatacept or rituximab following failure of initial TNFi in rheumatoid arthritis: the SWITCH RCT.
Brown S; Everett CC; Naraghi K; Davies C; Dawkins B; Hulme C; McCabe C; Pavitt S; Emery P; Sharples L; Buch MH
Health Technol Assess; 2018 Jun; 22(34):1-280. PubMed ID: 29900829
[TBL] [Abstract][Full Text] [Related]
18. Patient and rheumatologist perspectives on tapering DMARDs in rheumatoid arthritis: a qualitative study.
Hazlewood GS; Loyola-Sanchez A; Bykerk V; Hull PM; Marshall D; Pham T; Barber CEH; Barnabe C; Sirois A; Pope J; Schieir O; Richards D; Proulx L; Bartlett SJ
Rheumatology (Oxford); 2022 Feb; 61(2):606-616. PubMed ID: 33878168
[TBL] [Abstract][Full Text] [Related]
19. Influence of baseline modified Rheumatic Disease Comorbidity Index (mRDCI) on drug survival and effectiveness of biological treatment in patients affected with Rheumatoid arthritis, Spondyloarthritis and Psoriatic arthritis in real-world settings.
Iannone F; Salaffi F; Fornaro M; Di Carlo M; Gentileschi S; Cantarini L; Lopalco G
Eur J Clin Invest; 2018 Nov; 48(11):e13013. PubMed ID: 30079593
[TBL] [Abstract][Full Text] [Related]
20. Summary of AHRQ's comparative effectiveness review of drug therapy for rheumatoid arthritis (RA) in adults--an update.
Singh JA; Cameron DR
J Manag Care Pharm; 2012 May; 18(4 Supp C):S1-18. PubMed ID: 22656072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
